<DOC>
	<DOC>NCT01101932</DOC>
	<brief_summary>The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics (how the drug effects certain target sites of activity in the body) of escalating doses of oral PF-04308515 in healthy volunteers for 14 days as well as one oral dose of a tablet formulation administered for 1 day.</brief_summary>
	<brief_title>Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy males between 18 and 55 years, inclusive Healthy females between 18 and 44 years, inclusive Females are required to be surgically sterile Evidence or history of clinically significant disease Postmenopausal women History of intolerance or significant adverse effects with glucocorticoid therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics/Pharmacodynamics</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>